Patents by Inventor Xiangman Zhang

Xiangman Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9955971
    Abstract: In a method for treating an aortic arch disease, after an intraoperative stent is expanded in an aorta and at least one arch branch vessel, and before the vessel is exactly anastomosed with an incision, by blocking a thoracic aorta between the incision and an arch branch vessel closest to the incision, the intraoperative stent in the thoracic aorta is also blocked, so that blood is prevented from flowing from the incision, and a proximal orifice of the intraoperative stent, and the low body perfusion may be recovered in advance, thereby reducing the circulatory arrest time of the low body perfusion and reducing the time of ischemia of visceral organs and lower limbs of a patient. Meanwhile, the flow of a cerebral perfusion through the right axillary artery may be recovered to a normal flow in advance, and the time of ischemia of the brain of the patient is reduced.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: May 1, 2018
    Assignee: Lifetech Scientific (Shenzhen) Co. Ltd.
    Inventors: Zhiyun Xu, Xiangman Zhang, Lin Han, Deyuan Zhang, Benhao Xiao
  • Publication number: 20170189030
    Abstract: In a method for treating an aortic arch disease, after an intraoperative stent is expanded in an aorta and at least one arch branch vessel, and before the vessel is exactly anastomosed with an incision, by blocking a thoracic aorta between the incision and an arch branch vessel closest to the incision, the intraoperative stent in the thoracic aorta is also blocked, so that blood is prevented from flowing from the incision, and a proximal orifice of the intraoperative stent, and the low body perfusion may be recovered in advance, thereby reducing the circulatory arrest time of the low body perfusion and reducing the time of ischemia of visceral organs and lower limbs of a patient. Meanwhile, the flow of a cerebral perfusion through the right axillary artery may be recovered to a normal flow in advance, and the time of ischemia of the brain of the patient is reduced.
    Type: Application
    Filed: December 30, 2015
    Publication date: July 6, 2017
    Applicant: Lifetech Scientific (Shenzhen) Co., Ltd.
    Inventors: Zhiyun Xu, Xiangman Zhang, Lin Han, Deyuan Zhang, Benhao Xiao